PAPER Schindler SE, Galasko D, Pereira AC, Rabinovici GD, Salloway S, Suárez-Calvet M, Khachaturian AS, Mielke MM, Udeh-Momoh C, Weiss J, Batrla R, Bozeat S, Dwyer JR, Holzapfel D, Jones DR, Murray JF, Partrick KA, Scholler E, Vradenburg G, Young D, Algeciras-Schimnich A, Aubrecht J, Braunstein JB, Hendrix J, Hu YH, Mattke S, Monane M, Reilly D, Somers E, Teunissen CE, Shobin E, Vanderstichele H, Weiner MW, Wilson D, Hansson O

Acceptable performance of blood biomarker tests of amyloid pathology- recommendations from the Global CEO Initiative on Alzheimer's Disease.

Nat Rev Neurol. 2024 Jun 12; PubMed.

PAPER Lin D, Gold A, Kaye S, Atkinson JR, Tol M, Sas A, Segal B, Tontonoz P, Zhu J, Gao J

Arachidonic acid mobilization and peroxidation promote microglial dysfunction in Aβ pathology.

J Neurosci. 2024 Jun 12; PubMed.

PAPER Deczkowska A

Not so aDAMant after all: Plasticity of phagocytic microglia.

Immunity. 2024 Jun 11;57(6):1189-1191. PubMed.

PAPER Furlepa M, Zhang YP, Lobanova E, Kahanawita L, Vivacqua G, Williams-Gray CH, Klenerman D

Single-molecule characterization of salivary protein aggregates from Parkinson's disease patients: a pilot study.

Brain Commun. 2024;6(3):fcae178. Epub 2024 May 21 PubMed.

PAPER Wirths O, Lehnen C, Fricke M, Talucci I, Klafki HW, Morgado B, Lehmann S, Münch C, Liepold T, Wiltfang J, Rostagno A, Ghiso J, Maric HM, Jahn O, Weggen S

Amino-terminally elongated Aβ peptides are generated by the secreted metalloprotease ADAMTS4 and deposit in a subset of Alzheimer's disease brains.

Neuropathol Appl Neurobiol. 2024 Jun;50(3):e12991. PubMed.

PAPER Costa AS, Albrecht M, Reich A, Nikoubashman O, Schulz JB, Reetz K, Pinho J

Non-hemorrhagic imaging markers of cerebral amyloid angiopathy in memory clinic patients.

Alzheimers Dement. 2024 Jun 12; PubMed.

PAPER Rudroff T, Rainio O, Klén R

AI for the prediction of early stages of Alzheimer's disease from neuroimaging biomarkers- A narrative review of a growing field.

Neurol Sci. 2024 Jun 13; PubMed.

PAPER Andriuta D, Roussel M, Chene G, Fischer C, Mangin JF, Dubois B, Vellas B, Pasquier F, Tison F, Blanc F, Hanon O, Paquet C, Gabelle A, Ceccaldi M, Annweiler C, Krolak-Salmon P, David R, Rouch-Leroyer I, Benetos A, Moreaud O, Sellal F, Jalenques I, Vandel P, Bouteloup V, Godefroy O, MEMENTO Study Group

The pattern of cortical thickness associated with executive dysfunction in MCI and SCC: The MEMENTO cohort.

Rev Neurol (Paris). 2024 Jun 11; PubMed.

PAPER Koppelmans V, Ruitenberg MF, Schaefer SY, King JB, Jacobo JM, Silvester BP, Mejia AF, van der Geest J, Hoffman JM, Tasdizen T, Duff K

Classification of Mild Cognitive Impairment and Alzheimer's Disease Using Manual Motor Measures.

Neurodegener Dis. 2024 Jun 12; PubMed.

PAPER Ding X, Yin L, Zhang L, Zhang Y, Zha T, Zhang W, Gui B, Alzheimer's Disease Neuroimaging Initiative

Diabetes accelerates Alzheimer's disease progression in the first year post mild cognitive impairment diagnosis.

Alzheimers Dement. 2024 Jun 12; PubMed.

PAPER Chang HI, Huang CW, Huang SH, Hsu SW, Lin KJ, Ho TY, Wu HC, Chang CC

Distinct biological property of tau in tau-first cognitive proteinopathy: Evidence by longitudinal clinical neuroimaging profiles and compared with late-onset Alzheimer disease.

Psychiatry Clin Neurosci. 2024 Jun 12; PubMed.

PAPER Ghosh U, Tse E, Yang H, Shi M, Caro CD, Wang F, Merz GE, Prusiner SB, Southworth DR, Condello C

Cryo-EM structures reveal tau filaments from Down syndrome adopt Alzheimer's disease fold.

Acta Neuropathol Commun. 2024 Jun 12;12(1):94. PubMed.

PAPER Ning Z, Liu Y, Wan M, Zuo Y, Chen S, Shi Z, Xu Y, Li H, Ko H, Zhang J, Xiao S, Guo D, Tang Y

APOE2 protects against Aβ pathology by improving neuronal mitochondrial function through ERRα signaling.

Cell Mol Biol Lett. 2024 Jun 12;29(1):87. PubMed.

PAPER Kugler BA, Lysaker CR, Franczak E, Hauger BM, Csikos V, Stopperan JA, Allen JA, Stanford JA, Koch LG, Britton SL, Thyfault JP, Wilkins HM

Intrinsic aerobic capacity modulates Alzheimer's disease pathological hallmarks, brain mitochondrial function and proteome during aging.

Geroscience. 2024 Jun 13; PubMed.

PAPER Di Timoteo G, Giuliani A, Setti A, Biagi MC, Lisi M, Santini T, Grandioso A, Mariani D, Castagnetti F, Perego E, Zappone S, Lattante S, Sabatelli M, Rotili D, Vicidomini G, Bozzoni I

M6A reduction relieves FUS-associated ALS granules.

Nat Commun. 2024 Jun 12;15(1):5033. PubMed.